KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

QuidelOrtho (QDEL) Capital Expenditures (2021 - 2025)

QuidelOrtho (QDEL) has disclosed Capital Expenditures for 5 consecutive years, with $45.3 million as the latest value for Q4 2025.

  • Quarterly Capital Expenditures fell 4.03% to $45.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $188.2 million through Dec 2025, down 3.54% year-over-year, with the annual reading at $188.2 million for FY2025, 3.54% down from the prior year.
  • Capital Expenditures hit $45.3 million in Q4 2025 for QuidelOrtho, down from $49.2 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $106.9 million in Q4 2021 to a low of -$119.5 million in Q1 2023.
  • Historically, Capital Expenditures has averaged $40.2 million across 5 years, with a median of $47.2 million in 2024.
  • Biggest five-year swings in Capital Expenditures: soared 193.33% in 2023 and later crashed 31.19% in 2024.
  • Year by year, Capital Expenditures stood at $106.9 million in 2021, then crashed by 78.95% to $22.5 million in 2022, then soared by 116.0% to $48.6 million in 2023, then decreased by 2.88% to $47.2 million in 2024, then decreased by 4.03% to $45.3 million in 2025.
  • Business Quant data shows Capital Expenditures for QDEL at $45.3 million in Q4 2025, $49.2 million in Q3 2025, and $37.5 million in Q2 2025.